# Masato Takahashi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/masato-takahashi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,562 |
| Field | HER2/EGFR in Cancer Research |
| h-index | 63 |
| i10-index | 202 |
| Last Known Institution | Ibaraki Prefectural University of Health Sciences |
| OpenAlex ID | https://openalex.org/A5008946028 |
| ORCID iD | https://orcid.org/0000-0002-6641-9598 |
| Works | 577 |

## Researcher papers

- [Pembrolizumab for Early Triple-Negative Breast Cancer](https://scholariq.org/papers/pembrolizumab-for-early-triple-negative-breast-cancer/)
- [Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/neratinib-after-trastuzumab-based-adjuvant-therapy-in-her2-positive-breast/)
- [Guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992: Special writing group of the committee on rheumatic fever, endocarditis, and Kawasaki disease of the council on cardiovascular disease in the young, American Heart Association](https://scholariq.org/papers/guidelines-for-the-diagnosis-of-rheumatic-fever-jones-criteria-updated-1992/)

## Researcher topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Kawasaki Disease and Coronary Complications](https://scholariq.org/topics/kawasaki-disease-and-coronary-complications/)

## Researcher university

- [Ibaraki Prefectural University of Health Sciences](https://scholariq.org/institutions/ibaraki-prefectural-university-of-health-sciences/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.